首页 | 本学科首页   官方微博 | 高级检索  
检索        

番茄红素微囊的体内外药剂学行为
引用本文:王会娟,李馨儒,黄燕清,张云龙,胡新,刘艳.番茄红素微囊的体内外药剂学行为[J].药学学报,2005,40(9):787-791.
作者姓名:王会娟  李馨儒  黄燕清  张云龙  胡新  刘艳
作者单位:1. 北京大学,药学院,药剂学系,北京100083;华北制药集团,河北,石家庄,050015
2. 北京大学,药学院,药剂学系,北京100083
摘    要:目的考察番茄红素微囊的体外释放、番茄红素原料及番茄红素微囊在家犬体内的药代动力学、体外释放和体内吸收的相关性。方法用分光光度法测定释放介质中番茄红素的含量。用HPLC法测定家犬体内的番茄红素含量,数据用3P87程序处理,得到各主要药代动力学参数。体内吸收与体外释放进行点点相关。结果微囊体外释放呈肠溶性,原料及番茄红素微囊的T1/2α分别为7.30和15.06 h;T1/2β分别为28.10和46.76 h;Tmax分别为22.32和41.03 h;AUC0-∞分别为1.67和2.08 μg·h·L-1。体内外相关性良好。结论微囊较原料药呈现缓释特征,体内外相关性结果表明可以根据体外释放情况预测体内的吸收。

关 键 词:番茄红素  微囊  体外释放度  HPLC  药代动力学
文章编号:0513-4870(2005)09-0787-05
收稿时间:11 20 2004 12:00AM
修稿时间:2004-11-20

In vitro and in vivo pharmaceutical behaviors of lycopene microcapsules
WANG Hui-juan,LI Xin-ru,HUANG Yan-qing,ZHANG Yun-long,HU Xin,LIU Yan.In vitro and in vivo pharmaceutical behaviors of lycopene microcapsules[J].Acta Pharmaceutica Sinica,2005,40(9):787-791.
Authors:WANG Hui-juan  LI Xin-ru  HUANG Yan-qing  ZHANG Yun-long  HU Xin  LIU Yan
Institution:Department of Pharmaceutics, School of Pharmaceutical Sciences, Peking University, Beijing 100083, China.
Abstract:AIM: To evaluate in vitro release of lycopene microcapsules. Pharmacokinetic parameters of lycopene microcapsule and lycopene powder as reference were estimated after a single dose of oral administration to dogs. The relationship between in vitro dissolution and in vivo absorption was investigated. METHODS: The content of lycopene in the release medium was determined by UV spectroscopy method. Health hybrid male dogs were used as experiment subjects and lycopene powder used as standard to estimate the pharmacokinetics of lycopene microcapsules. HPLC method was used to assay the concentration of lycopene in dog plasma. Pharmacokinetics parameters were estimated by 3P87 program. The drug release percentage in stimulated intestinal fluid was compared with the absorption at a given time point. RESULTS: The release profiles of lycopene from microcapsule showed that the lycopene gelatin microcapsule exhibited enteric property. The pharmacokinetics parameters estimated after oral administration of lycopene powder and lycopene microcapsule in a single dose of 2.5 mg x kg(-1) body weight to dogs were 7.30 h, 15.06 h for T1/2alpha; 28.10 h, 46.76 h for T1/2beta; 22.32 h, 41.03 h for T(max); 1.67 microg x h x L(-1), 2.08 microg x h x L(-1) for AUC(0-infinity), respectively. The concentration-time curves could be fitted to a two-compartment model for both the lycopene powder and the lycopene microcapsule analyzed by 3P87 program. The relationship between in vitro dissolution and in vivo absorption was found to have good correlation (r = 0. 981 9) was found. CONCLUSION: It could be concluded that lycopene microcapsule was a sustained release dosage form. The result of release in vitro could be used to predict the absorption in vivo.
Keywords:lycopene  microcapsule  in vitro dissolution  HPLC  pharmacokinetics
本文献已被 CNKI 万方数据 等数据库收录!
点击此处可从《药学学报》浏览原始摘要信息
点击此处可从《药学学报》下载免费的PDF全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号